SPONSOR
Forward Pharmaceuticals Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Stage IVER+/HER2- Breast CancerBreast Cancer Stage IBreast Cancer Stage IILocally Advanced Breast Cancer (LABC)ER+ Breast Cancer
NCT06064812 Phase 1, Phase 2
Recruiting
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Metastatic Breast Cancer
NCT07002177 Phase 1, Phase 2
Recruiting
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Metastatic Breast Cancer